Journal of endocrinological investigation
Metabolic and renal effects of combined SGLT-2 inhibitors and GLP1-R agonists therapy in type 2 diabetes: a real-world analysis across DKD and non-DKD patients.
L Mazzeo, S Wolde Sellasie, C Pecchioli, P Di Perna, S Zaccaria, P Sperti, I Nardone, L Giurato, D Della-Morte, M Caprio, A Bellia, L Uccioli
Published: 202510.1007/s40618-025-02756-5
Abstract
PURPOSE: This study aimed to evaluate the one-year metabolic and renal effects of combined therapy with SGLT-2 inhibitors and GLP-1 receptor (GLP-1R) agonists in patients with type 2 diabetes mellitus (T2DM), both with and without diabetic kidney dis…
Preview only. Read the full abstract at the source